The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.
Open accessAbstract
The immunodominant antimitochondrial antibody response in patients with primary biliary cirrhosis (PBC) is directed against the E2 component of the pyruvate dehydrogenase complex (PDC-E2). Based on our earlier observations regarding peripheral blood mononuclear cell (PBMC) T cell epitopes, we reasoned that a comparative analysis of the precursor frequencies of PDC-E2 163-176-specific T cells isolated from PBMC, regional hepatic lymph nodes, and from the liver of PBC patients would provide insight regarding the role of T cells in PBC. Results showed a disease-specific 100-150-fold increase in the precursor frequency of PDC-E2 163-176-specific T cells in the hilar lymph nodes and liver when compared with PBMC from PBC patients. Interestingly, autoreactive T cells and autoantibodies from PBC patients both recognize the same dominant epitope. In addition, we demonstrated cross-reactivity of PDC-E2 peptide 163-176-specific T cell clones with PDC-E2 peptide 36-49 and OGDC-E2 peptide 100-113 thereby identifying a common T cell epitope "motif" ExETDK. The peptide 163-176-specific T cell clones also reacted with purified native PDC-E2, suggesting that this epitope is not a cryptic determinant. These data provide evidence for a major role for PDC-E2 peptide 163-176 and/or peptides bearing a similar motif in the pathogenesis of PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gershwin, M. E., Mackay, I. R., Sturgess, A., & Coppel, R. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3525 · Cited by 557
Self-citationIdentification and analysis of the major M2 autoantigens in primary biliary cirrhosis.
Fussey, S. P., Guest, J. R., James, O. F., Bassendine, M. F., & Yeaman, S. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8654 · Cited by 273
Moteki, S., Leung, P. S., Dickson, E. R., Van Thiel, D. H., Galperin, C., Buch, T., Alarcon-Segovia, D., Kershenobich, D., Kawano, K., Coppel, R. L., et al. (1996) · Hepatology · doi:10.1002/hep.510230307 · Cited by 133
Self-citation
Cited by
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Self-citationLindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
The immunobiology and pathophysiology of primary biliary cirrhosis
Hirschfield, G. M., & Gershwin, M. E. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164014 · Cited by 315
Self-citationIdentification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
Kita, H., Lian, Z.-X., Van de Water, J., He, X.-S., Matsumura, S., Kaplan, M., Luketic, V., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010956 · Cited by 292
Self-citationPathogenesis of cholestatic liver disease and therapeutic approaches
Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.004 · Cited by 287
Self-citationThe causes of primary biliary cirrhosis: Convenient and inconvenient truths
Gershwin, E. M., & Mackay, I. R. (2008) · Hepatology · doi:10.1002/hep.22042 · Cited by 274
Lleo, A., Wang, G.-Q., Gershwin, M. E., & Hirschfield, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31607-x · Cited by 253
Self-citationKita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z.-X., Van de Water, J., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214698 · Cited by 222
Self-citationLleo, A., Liao, J., Invernizzi, P., Zhao, M., Bernuzzi, F., Ma, L., Lanzi, G., Ansari, A. A., Coppel, R. L., Zhang, P., et al. (2012) · Hepatology · doi:10.1002/hep.24630 · Cited by 133
Self-citationShimoda, S., Harada, K., Niiro, H., Shirabe, K., Taketomi, A., Maehara, Y., Tsuneyama, K., Nakanuma, Y., Leung, P., Ansari, A. A., et al. (2011) · Hepatology · doi:10.1002/hep.24194 · Cited by 126
“A more detailed analysis of the effector mechanisms involved in the pathogenesis of human PBC has led us to suggest that in addition to the documented adaptive autoimmune responses there is also a direct role of innate immune responses in the biliary pathology of PBC (2,5,7-9).”
Self-citationSasaki, M., Ikeda, H., Yamaguchi, J., Nakada, S., & Nakanuma, Y. (2008) · Hepatology · doi:10.1002/hep.22348 · Cited by 125
Chuang, Y.-H., Lian, Z.-X., Tsuneyama, K., Chiang, B.-L., Ansari, A. A., Coppel, R. L., & Eric Gershwin, M. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.04.001 · Cited by 121
Self-citationThe challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114
Self-citationSasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.56 · Cited by 114
Cx3cl1 (Fractalkine): A Signpost for Biliary Inflammation in Primary Biliary Cirrhosis
Shimoda, S., Harada, K., Niiro, H., Taketomi, A., Maehara, Y., Tsuneyama, K., Kikuchi, K., Nakanuma, Y., Mackay, I. R., Gershwin, E. M., et al. (2010) · Hepatology · doi:10.1002/hep.23318 · Cited by 108
Self-citationNatural killer cells regulate T cell immune responses in primary biliary cirrhosis
Shimoda, S., Hisamoto, S., Harada, K., Iwasaka, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Shirabe, K., Ikegami, T., et al. (2015) · Hepatology · doi:10.1002/hep.28122 · Cited by 82
“LMC populations were isolated as previously described.(7,12) Briefly, liver specimens were first digested with 1 mg/mL of collagenase type I.”
Self-citationWang, J. J., Yang, G.-X., Zhang, W. C., Lu, L., Tsuneyama, K., Kronenberg, M., Véla, J. L., Lopez-Hoyos, M., He, X.-S., Ridgway, W. M., et al. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12224 · Cited by 74
Self-citationHisamoto, S., Shimoda, S., Harada, K., Iwasaka, S., Onohara, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Ikegami, T., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.08.006 · Cited by 57
Self-citationThe liver as a central "hub" of the immune system: pathophysiological implications
Ronca, V., Gerussi, A., Collins, P., Parente, A., Oo, Y. H., & Invernizzi, P. (2025) · Physiological Reviews · doi:10.1152/physrev.00004.2023 · Cited by 59
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yang, Y., Choi, J., Chen, Y., Invernizzi, P., Yang, G., Zhang, W., Shao, T., Jordan, F., Nemeria, N. S., Coppel, R. L., et al. (2022) · Hepatology · doi:10.1002/hep.32172 · Cited by 44
Self-citationRole of autoantibodies in the clinical management of primary biliary cholangitis
Rigopoulou, E. I., & Bogdanos, D. P. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i12.1795 · Cited by 30
The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update
Hitomi, Y., & Nakamura, M. (2023) · Genes · doi:10.3390/genes14020405 · Cited by 26
Self-citationMaking Sense of Autoantibodies in Cholestatic Liver Diseases
Marzorati, S., Invernizzi, P., & Lleo, A. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.003 · Cited by 23
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects
Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A. (2025) · Hepatology · doi:10.1097/hep.0000000000001225 · Cited by 22
Metadata
- Authors
- Shimoda, S., Van de Water, J., Ansari, A., Nakamura, M., Ishibashi, H., Coppel, R. L., Lake, J., Keeffe, E. B., Roche, T. E., & Gershwin, M. E.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-11-15
- Volume
- 102
- Issue
- 10
- Pages
- 1831-1840
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2055420557
- Cited by
- 250
- References
- 3
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.